Trial Profile
Treatment of superficial voluminous complicated slow-flow vascular malformations with sirolimus: a phase 2 trial in children observational-phase designed
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Vascular malformations
- Focus Pharmacodynamics
- Acronyms PERFORMUS
- 15 Sep 2021 Primary endpoint (Change of volume of the Vascular Malformation) has not been met as per results published in the JAMA Dermatology
- 15 Sep 2021 Results published in the JAMA Dermatology
- 17 Sep 2019 Status changed from active, no longer recruiting to completed.